1. |
Wu KH, Lü XD, Liu YL. Recent progress of pediatric cardiac surgery in China. Chin Med J (Engl), 2006, 119(23): 2005-2012.
|
2. |
Rajakaruna C, Rogers CA, Angelini GD, et al. Risk factors for and economic implications of prolonged ventilation after cardiac surgery. J Thorac Cardiovasc Surg, 2005, 13(5): 1270-1277.
|
3. |
潘沱, 王旭. 法洛四联症根治术后急性肾损伤的危险因素分析. 中国胸心血管外科临床杂志, 2017, 24(7): 495-500.
|
4. |
Xie O, Brizard CP, d'Udekem Y, et al. Outcomes of repair of complete atrioventricular septal defect in the current era. Eur J Cardiothorac Surg, 2014, 45(4): 610-617.
|
5. |
Tatebe S, Saji Y, Aoki K, et al. Intermediate type atrioventricular septal defect in the elderly. Ann Thorac Surg, 2006, 81(5): 1888-1890.
|
6. |
朱正艳, 严中亚, 雷虹, 等. 错过合适年龄段完全性心内膜垫缺损外科矫治疗效分析(附 15 例报告). 安徽医学, 2013, 34(11): 1604-1606.
|
7. |
D’Alto M, Diller GP. Pulmonary hypertension in adults with congenital heart disease and Eisenmenger syndrome: current advanced management strategies. Heart, 2014, 100(17): 1322-1328.
|
8. |
Denault AY, Pearl RG, Michler RE, et al. Tezosentan and right ventricular failure in patients with pulmonary hypertension undergoing cardiac surgery: the TACTICS trial. J Cardiothorac Vasc Anesth, 2013, 27(6): 1212-1217.
|
9. |
Rosenzweig EB, Barst RJ. Congenital heart disease and pulmonary hypertension: pharmacology and feasibility of late surgery. Prog Cardiovasc Dis, 2012, 55(2): 128-133.
|
10. |
Thunberg CA, Gaitan BD, Grewal A, et al. Pulmonary hypertension in patients undergoing cardiac surgery: pathophysiology, perioperative management, and outcomes. J Cardiothorac Vasc Anesth, 2013, 27(3): 551-572.
|
11. |
Skride A, Sablinskis K, Lejnieks A, et al. Pulmonary hypertension in adults with congenital heart disease: First data from Latvian PAH registry. Eur J Intern Med, 2016, 36: e20-e21.
|
12. |
Paparella D, Yau TM, Young E. Cardiopulmonary bypass induced inflammation: pathophysiology and treatment. An update. Eur J Cardiothorac Surg, 2002, 21(2): 232-244.
|
13. |
Bhatia M, Moochhala S. Role of inflammatory mediators in the pathophysiology of acute respiratory distress syndrome. J Pathol, 2004, 202(2): 145-156.
|
14. |
Güvener M, Korun O, Demirtürk OS. Risk factors for systemic inflammatory response after congenital cardiac surgery. J Card Surg, 2015, 30(1): 92-96.
|
15. |
Elmistekawy E, Rubens F, Hudson C, et al. Preoperative anaemia is a risk factor for mortality and morbidity following aortic valve surgery. Eur J Cardiothorac Surg, 2013, 44(6): 1051-1055.
|
16. |
Armas-Loughran B, Kalra R, Carson JL. Evaluation and management of anemia and bleeding disorders in surgical patients. Med Clin North Am, 2003, 87(1): 229-242.
|
17. |
Levine EA, Rosen AL, Sehgal LR, et al. Erythropoietin deficiency after coronary artery bypass procedures. Ann Thorac Surg, 1991, 51(5): 764-766.
|
18. |
Goodnough LT, Vizmeg K, Sobecks R, et al. Prevalence and classification of anemia in elective orthopedic surgery patients: implications for blood conservation programs. Vox Sang, 1992, 63(2): 90-95.
|
19. |
王志维, 陶卫平, 康敢军. 重组人红细胞生成素在体外循环围术期中的作用. 中国胸心血管外科临床杂志, 2002, 9(1): 72-73.
|